| Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells K Tahara, T Sakai, H Yamamoto, H Takeuchi, N Hirashima, Y Kawashima International journal of pharmaceutics 382 (1-2), 198-204, 2009 | 222 | 2009 |
| Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery K Tahara, T Sakai, H Yamamoto, H Takeuchi, Y Kawashima International journal of pharmaceutics 354 (1-2), 210-216, 2008 | 173 | 2008 |
| Antimicrobial photodynamic therapy using a diode laser with a potential new photosensitizer, indocyanine green‐loaded nanospheres, may be effective for the clearance of P … A Nagahara, A Mitani, M Fukuda, H Yamamoto, K Tahara, I Morita, ... Journal of periodontal research 48 (5), 591-599, 2013 | 150 | 2013 |
| Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly (D, L-lactide-co-glycolide) nanospheres for inflammatory bowel disease K Tahara, S Samura, K Tsuji, H Yamamoto, Y Tsukada, Y Bando, ... Biomaterials 32 (3), 870-878, 2011 | 133 | 2011 |
| Advanced continuous flow platform for on‐demand pharmaceutical manufacturing P Zhang, N Weeranoppanant, DA Thomas, K Tahara, T Stelzer, ... Chemistry–A European Journal 24 (11), 2776-2784, 2018 | 100 | 2018 |
| Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes T Fujisawa, H Miyai, K Hironaka, T Tsukamoto, K Tahara, Y Tozuka, M Ito, ... International journal of pharmaceutics 436 (1-2), 564-567, 2012 | 100 | 2012 |
| Brain targeting with surface-modified poly (D, L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration K Tahara, Y Miyazaki, Y Kawashima, J Kreuter, H Yamamoto European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 84-88, 2011 | 87 | 2011 |
| Retinal drug delivery using eyedrop preparations of poly-L-lysine-modified liposomes H Sasaki, K Karasawa, K Hironaka, K Tahara, Y Tozuka, H Takeuchi European Journal of Pharmaceutics and Biopharmaceutics 83 (3), 364-369, 2013 | 86 | 2013 |
| Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as … M Murata, K Nakano, K Tahara, Y Tozuka, H Takeuchi European Journal of Pharmaceutics and Biopharmaceutics 80 (2), 340-346, 2012 | 85 | 2012 |
| Chitosan-modified poly (D, L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects K Tahara, H Yamamoto, N Hirashima, Y Kawashima European Journal of Pharmaceutics and Biopharmaceutics 74 (3), 421-426, 2010 | 85 | 2010 |
| Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles K Tahara, K Karasawa, R Onodera, H Takeuchi Asian journal of pharmaceutical sciences 12 (4), 394-399, 2017 | 74 | 2017 |
| Continuous spherical crystallization of albuterol sulfate with solvent recycle system K Tahara, M O’Mahony, AS Myerson Crystal Growth & Design 15 (10), 5149-5156, 2015 | 67 | 2015 |
| Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: Effect of emulsion formulations and surface modification L Ying, K Tahara, H Takeuchi International journal of pharmaceutics 453 (2), 329-335, 2013 | 64 | 2013 |
| Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D, L-lactide-co-glycolide) nanospheres for gene delivery K Tahara, H Yamamoto, Y Kawashima European journal of pharmaceutics and biopharmaceutics 75 (2), 218-224, 2010 | 60 | 2010 |
| Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events M Nakamura, R Umetsu, J Abe, T Matsui, N Ueda, Y Kato, S Sasaoka, ... Journal of Pharmaceutical Health Care and Sciences 1, 1-9, 2015 | 59 | 2015 |
| Characterization of tableting properties measured with a multi-functional compaction instrument for several pharmaceutical excipients and actual tablet formulations T Osamura, Y Takeuchi, R Onodera, M Kitamura, Y Takahashi, K Tahara, ... International journal of pharmaceutics 510 (1), 195-202, 2016 | 56 | 2016 |
| Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system A Fukuda, K Tahara, Y Hane, T Matsui, S Sasaoka, H Hatahira, ... PLoS One 12 (9), e0185654, 2017 | 53 | 2017 |
| Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration M Murata, K Tahara, H Takeuchi European Journal of Pharmaceutics and Biopharmaceutics 86 (1), 115-119, 2014 | 50 | 2014 |
| Formulation design of hydroxypropyl cellulose films for use as orally disintegrating dosage forms Y Takeuchi, K Umemura, K Tahara, H Takeuchi Journal of Drug Delivery Science and Technology 46, 93-100, 2018 | 48 | 2018 |
| Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration M Murata, T Yonamine, S Tanaka, K Tahara, Y Tozuka, H Takeuchi Journal of pharmaceutical sciences 102 (4), 1281-1289, 2013 | 45 | 2013 |
